APA

Guerard F., Barbet J., Chatal J. F., Kraeber-Bodere F., Cherel M. & Haddad F. (20151026). Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. : The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.

Chicago

Guerard F, Barbet J, Chatal J F, Kraeber-Bodere F, Cherel M and Haddad F. 20151026. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. : The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.

Harvard

Guerard F., Barbet J., Chatal J. F., Kraeber-Bodere F., Cherel M. and Haddad F. (20151026). Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. : The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.

MLA

Guerard F, Barbet J, Chatal J F, Kraeber-Bodere F, Cherel M and Haddad F. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. : The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of. 20151026.